Clinical Trial Update: Use of Indocyanine Green Angiography in Critical Limb Ischemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on using Indocyanine Green angiography in critical limb ischemia, a severe form of peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Arterial Disease

Drugs mentioned

• Indocyanine Green (ICG) (indocyanine green)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Peripheral Arterial Disease | Phase 3 | Status: UNKNOWN